A study on clinical and pathologic features in lupus nephritis with mainly IgA deposits and a literature review

Clin Dev Immunol. 2013:2013:289316. doi: 10.1155/2013/289316. Epub 2013 Sep 24.

Abstract

Objective: To study the clinical and pathologic features of systemic lupus erythematosus (SLE) that has atypical lupus nephritis (LN) with mainly IgA deposits.

Methods: We searched the SLE patients who had nephritis with mainly IgA deposits in our hospital and selected the information including clinical manifestations, laboratory tests, treatments, and prognosis.

Results: From January 2009 to June 2012, 5 patients were definitely diagnosed as SLE according to both 1982 and 2009 ACR classification criteria. But renal biopsy showed that all cases had mainly IgA deposits and were free of IgG, C1q, and fibrinogen-related antigen deposits under immunofluorescent microscopy, which did not match with typical LN. There were 2 males and 3 females, aging from 31 to 64 years and with an average of (42.20 ± 13.59) years. The 5 cases had multiple-system involvements, mainly the renal system. Compared to primary IgAN, the atypical LN showed some differences: older than primary IgAN, more women than men, no previous infection history, lower incidence of serum IgA elevation, and ACL positive rate as high as 100%.

Conclusion: Nephritis with mainly IgAN deposits, as an atypical LN, may be a special subtype of SLE.

Publication types

  • Review

MeSH terms

  • Adult
  • Autoantibodies / blood
  • Autoantibodies / immunology
  • Biopsy
  • Female
  • Humans
  • Immunoglobulin A / immunology*
  • Immunoglobulin A / metabolism
  • Immunosuppressive Agents / therapeutic use
  • Kidney / immunology
  • Kidney / pathology
  • Lupus Nephritis / diagnosis*
  • Lupus Nephritis / drug therapy
  • Lupus Nephritis / immunology*
  • Lupus Nephritis / pathology
  • Male
  • Middle Aged
  • Prednisolone / therapeutic use
  • Prognosis
  • Treatment Outcome

Substances

  • Autoantibodies
  • Immunoglobulin A
  • Immunosuppressive Agents
  • Prednisolone